Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nnaji, Chukwudi A"'
Autor:
Nnaji CA; Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa., Wiysonge CS; Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.; Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.; HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Cooper S; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.; Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.; Division of Social & Behavioural Sciences, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa., Mayeye A; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa., Luphondo L; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa., Mabuya T; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa., Kalui N; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa., Lesosky M; Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK., Ndwandwe D; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 31; Vol. 19 (1), pp. 2162771. Date of Electronic Publication: 2023 Jan 05.
Autor:
Ndwandwe D; Cochrane South Africa, South African Medical Research Council , Cape Town, South Africa., Nnaji CA; Cochrane South Africa, South African Medical Research Council , Cape Town, South Africa.; School of Public Health and Family Medicine, University of Cape Town , Cape Town, South Africa., Mashunye T; Cochrane South Africa, South African Medical Research Council , Cape Town, South Africa.; School of Public Health and Family Medicine, University of Cape Town , Cape Town, South Africa., Uthman OA; Warwick-Centre for Applied Health Research and Delivery (WCAHRD), University of Warwick Medical School , Coventry, UK.; Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Stellenbosch University , Cape Town, South Africa., Wiysonge CS; Cochrane South Africa, South African Medical Research Council , Cape Town, South Africa.; School of Public Health and Family Medicine, University of Cape Town , Cape Town, South Africa.; Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Stellenbosch University , Cape Town, South Africa.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jan 02; Vol. 17 (1), pp. 247-254. Date of Electronic Publication: 2020 Jul 23.
Autor:
Adamu AA; Cochrane South Africa, South African Medical Research Council , Tygerberg, South Africa.; Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa., Gadanya MA; Department of Community Medicine, Bayero University/Aminu Kano Teaching Hospital , Kano, Nigeria., Jalo RI; Department of Community Medicine, Bayero University/Aminu Kano Teaching Hospital , Kano, Nigeria., Uthman OA; Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa.; Warwick-Centre for Applied Health Research and Delivery (WCAHRD), Division of Health Sciences, University of Warwick Medical School , Coventry, UK., Nnaji CA; Cochrane South Africa, South African Medical Research Council , Tygerberg, South Africa.; School of Public Health and Family Medicine, University of Cape Town , Cape Town, South Africa., Bello IW; Department of Public Health and Disease Control, Kano State Ministry of Health , Kano, Nigeria., Wiysonge CS; Cochrane South Africa, South African Medical Research Council , Tygerberg, South Africa.; Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa.; School of Public Health and Family Medicine, University of Cape Town , Cape Town, South Africa.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2020 Apr; Vol. 19 (4), pp. 395-405. Date of Electronic Publication: 2020 Apr 10.
Autor:
Wiyeh AB; a Cochrane South Africa , South African Medical Research Council , Cape Town , South Africa., Cooper S; a Cochrane South Africa , South African Medical Research Council , Cape Town , South Africa., Nnaji CA; a Cochrane South Africa , South African Medical Research Council , Cape Town , South Africa.; b School of Public Health and Family Medicine , University of Cape Town , Cape Town , South Africa., Wiysonge CS; a Cochrane South Africa , South African Medical Research Council , Cape Town , South Africa.; c Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences , Stellenbosch University , Stellenbosch , South Africa.; d Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine , University of Cape Town , Cape Town , South Africa.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2018 Dec; Vol. 17 (12), pp. 1063-1070. Date of Electronic Publication: 2018 Nov 30.